8-K/A
filed November 26, 2024, 6:59 PM ET
ticker RXRX
CIK 0001601830
M&A
confidence high
sentiment neutral
materiality 0.50
Recursion issues 102.3M shares to close Exscientia acquisition
RECURSION PHARMACEUTICALS, INC.
- 102,298,808 shares of Class A common stock issuable to Exscientia shareholders and option/RSU holders.
- Shares issued in exchange for Exscientia ordinary shares and canceled equity awards under the Transaction Agreement.
- Issuance exempt from registration under Securities Act Section 3(a)(10).
- Transaction closed on November 20, 2024; this Amendment provides final share count.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001601830-24-000224
- form_type
- 8-K/A
- ticker
- RXRX
- cik
- 0001601830
- company_name
- RECURSION PHARMACEUTICALS, INC.
- filed_at
- 2024-11-26T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:08.935386+00:00
- generated_at
- 2026-05-29T17:52:13.476900+00:00
- sec_items
- ["3.02"]
- event_type
- m_and_a
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001601830-24-000224
- json_url
- https://secwatch.observer/filing/0001601830-24-000224.json
- markdown_url
- https://secwatch.observer/filing/0001601830-24-000224.md
- text_url
- https://secwatch.observer/filing/0001601830-24-000224.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183024000224/0001601830-24-000224-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183024000224/rxrx-20240808.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
NOG
NOG completes Parallax acquisition for CA$237M cash and 3.7M shares
NORTHERN OIL & GAS, INC.
June 1, 2026, 4:19 PM ET
m_and_a
Items 1.01, 3.02, 9.01
same SEC item: 3.02
same event type: m_and_a
similar materiality
Filing page
SEC filing
NCPL
Netcapital acquires NetNudge AI Agent Platform assets from Codesharp for up to 1.2M Series A Preferred shares
Netcapital Inc.
May 28, 2026, 4:05 PM ET
m_and_a
Items 1.01, 3.02, 3.03, 9.01
same SEC item: 3.02
same event type: m_and_a
similar materiality
Filing page
SEC filing
OCFC
OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus
OCEANFIRST FINANCIAL CORP
June 1, 2026, 5:19 PM ET
m_and_a
Items 1.01, 3.02, 2.01, 2.03, 3.03, 5.02, 5.03, 7.01, 9.01
same SEC item: 3.02
same event type: m_and_a
Filing page
SEC filing
WFRD
Weatherford to acquire NCS Multistage; issues shares to Advent in private placement
Weatherford International plc
June 1, 2026, 4:28 PM ET
m_and_a
Items 3.02
same SEC item: 3.02
same event type: m_and_a
Filing page
SEC filing
RLYB
Rallybio to merge with Avenzo Therapeutics; pre-merger Avenzo holders to own ~56.6% of combined co
Rallybio Corp
June 1, 2026, 8:07 AM ET
m_and_a
Items 1.01, 3.02, 5.01, 5.02, 7.01, 9.01
same SEC item: 3.02
same event type: m_and_a
Filing page
SEC filing
GIG
Hadron Energy closes SPAC merger with GigCapital7; 84% of public shares redeemed
GigCapital7 Corp.
May 29, 2026, 7:45 PM ET
m_and_a
Items 2.01, 3.02, 5.02, 9.01, 3.03, 4.01, 5.01, 5.03, 5.06, 8.01
same SEC item: 3.02
same event type: m_and_a
Filing page
SEC filing
Matternet, Inc.
Matternet goes public via reverse merger with Los Altos Ventures, $27.6M PIPE
Matternet, Inc.
May 29, 2026, 5:21 PM ET
m_and_a
Items 1.01, 2.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.06, 9.01
same SEC item: 3.02
same event type: m_and_a
Filing page
SEC filing
NNE
Nano Nuclear acquires STS for up to $13M, adds nuclear logistics and $7.1M revenue
Nano Nuclear Energy Inc.
May 29, 2026, 6:30 AM ET
m_and_a
Items 1.01, 2.01, 3.02, 5.02, 7.01, 9.01
same SEC item: 3.02
same event type: m_and_a
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.